Showing results (1281-1290 of 2,524) with videos related to
Sort By:
Pageof 253
Drug Testing and Analysis|November 22, 2011
Carbon isotope ratio determination and investigation of seized testosterone preparationsGuro Forsdahl, Christian Östreicher, Martina Koller, et al.Drug Testing and Analysis|November 22, 2011
Quantification of pralidoxime (2-PAM) in urine by ion pair chromatography-diode array detection: application to in vivo samples from minipigHarald John, Michael Eddleston, R Eddie Clutton, et al.Drug Testing and Analysis|November 22, 2011
Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish internet companyLotte A Reitzel, Petur W Dalsgaard, Irene B Müller, et al.Drug Testing and Analysis|December 8, 2011
Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrationsE Solymos, S Guddat, H Geyer, et al.Drug Testing and Analysis|December 8, 2011
Studies of methylhexaneamine in supplements and geranium oilA Lisi, N Hasick, R Kazlauskas, et al.Drug Testing and Analysis|January 4, 2012
Urinary concentrations of ethyl glucuronide and ethyl sulfate as thresholds to determine potential ethanol-induced alteration of steroid profilesD Thieme, J Grosse, L Keller, et al.Drug Testing and Analysis|February 25, 2012
Cannabis - from cultivar to chemovarA Hazekamp, J T FischedickDrug Testing and Analysis|February 25, 2012
Competition radioligand binding assays for the investigation of bispyridinium compound affinities to the human muscarinic acetylcholine receptor subtype 5 (hM(5) )K V Niessen, J E H Tattersall, C M Timperley, et al.Drug Testing and Analysis|February 29, 2012
Monitoring of aglycons of yew glycosides (3,5-dimethoxyphenol, myrtenol and 1-octen-3-ol) as first indicator of yew presenceV Varlet, M AugsburgerDrug Testing and Analysis|March 1, 2012
The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™)Pierce Kavanagh, Daniel Angelov, John O'Brien, et al.Pageof 253